Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TEAM: Effects of Abrupt Methylphenidate Discontinuation in ADHD
NCT02293655Phase 4Completed
- Sponsor
- Cincinnati Children's Hospital Medical Center
- Start
- Jan 2015
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of methylphenidate hydrochloride extended-release chewable tablet in attention deficit hyperactivity disorder (ADHD), sponsored by Cincinnati Children's Hospital Medical Center. Started Jan 2015; status: completed.
02
Drugs
methylphenidate hydrochloride extended-release chewable tablet
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT02293655.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02293655.